Search Results 2681-2690 of 14252 for Obesity/Overweight Treatment

1. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma - Mayo Clinic

   The purpose of this study is to see how well lorvotuzumab mertansine works in treating younger patients with Wilms tumor, rhabdomyosarcoma, neuroblastoma, ...

2. Ibrutinib, Lenalidomide, And Dexamethasone In Treating Patients With Multiple Myeloma Ineligible For Transplant - Mayo Clinic

   Ibrutinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as lenalidomide and ...

3. A Study Of Selpercatinib To Treat Participants With RET-Mutant Medullary Thyroid Cancer - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

4. Biomarkers of Treatment Response in Rheumatoid Arthritis - Mayo Clinic

   About this study. Objective: Identify a microbial biomarker signature that is predictive of treatment response in patients with rheumatoid arthritis (RA).

5. Rollover Study Of Cenicriviroc For The Treatment Of Liver Fibrosis In Participants With Nonalcoholic Steatohepatitis - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

6. A Study To Compare Elacestrant Vs. Standard Of Care For The Treatment Of Patients With ER+/HER2- Advanced Breast Cancer - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

7. Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia - Mayo Clinic

   This phase III trial is studying the side effects and how well giving dasatinib together with combination chemotherapy works in treating young patients with ...

8. Radiation Therapy With Or Without Chemotherapy In Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery - Mayo Clinic

   It is not yet known whether radiation therapy is more effective when given together with chemotherapy or alone after surgery in treating salivary gland tumors.

9. Dabrafenib Combined With Trametinib After Radiation Therapy In Treating Patients With Newly-Diagnosed High-Grade Glioma - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

10. MAYO CLINIC HEALTH LETTER

    Europeans give dark chocolate healthy status. OBESITY SURGERY............ ... Inadequate treatment of an underly-.